Abstract
The availability of suitable radioligands is one of the important limiting factors in the further development of positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging of human cerebral receptors and transporters. Currently, the available ligands allow the investigation of 5-HT2A, 5-HT1A and dopamine D2 receptors, and the serotonin and dopamine transporter. 5-HT2A receptors have been investigated most extensively. Overall findings are rather discordant. Among others, heterogeneity and size of clinical samples, previous treatments and, more particularly as far as 5-HT2A receptors are concerned, suicidality could be major confounding variables. Most, albeit not all, studies find an increased 5-HT2A ligand binding after SSRI treatment. Findings on the dopamine D2 receptors in depression are controversial, but successful SSRI treatment seems to be associated with increased D2 ligand binding. A few studies have looked at the 5-HT1A receptor and demonstrated decreases in binding. The one study which looked at the effect of an SSRI treatment found no effect. Serotonin transporter availability seems to be reduced in depression; its blockade was confirmed in those studies that investigated this transporter on SSRI treatment. Only one study has looked at the dopamine transporter and showed an increased ligand uptake.
Keywords
- Positron Emission Tomography
- Depressed Patient
- Positron Emission Tomography Imaging
- Dopamine Transporter
- Serotonin Transporter
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Attar-Lévy D, Martinot J-L, Blin J et al (1999) The cortical serotonin2 receptors studies with positron-emission tomography and [18F]setoperone during depressive illness and antidepressant treatment with clomipramine. Biol Psychiatry 45:180–186
Audenaert K, Van Laere K, Dumont F et al (2001) Decreased frontal serotonin 5-HT2A receptor binding index in deliberate self-harm patients. Eur J Nuc Med 28:175–182
Baeken C, D’haenen H, Flamen P et al (1998) 123I-5-I-R91150, a new single-photon emission tomography ligand for 5-HT2A receptors: influence of age and gender in healthy subjects. Eur J Nucl Med 25:1617–1622
Biver F, Wikler D, Lotstra F et al (1997) Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex. Br J Psychiatry 171:444–448
D’haenen H, Bossuyt A (1994) Dopamine D2 receptors in depression measured with single photon emission computed tomography. Biol Psychiatry 35:128–132
D’haenen H, Schins A et al (2003) Eur Neuropsychopharmacol (in press)
D’haenen H, Bossuyt A, Mertens J et al (1992) SPECT imaging of serotonin2 receptors in depression. Psychiatry Res Neuroimaging 45:227–237
D’haenen H, Steenssens D, Bossuyt A (1999) Successful antidepressant treatment with SSRIs is associated with an increase in D2 binding. Int J Neuropsychopharmacol 2:S14
Drevets WC, Frank E, Price JC et al (1999) PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46:1375–1387
Ebert D, Feistel H, Kaschka W et al (1994) Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation-preliminary results. Biol Psychiatry 35:880–885
Ebert D, Feistel H, Loew T, Pirner A (1996) Dopamine and depression — striatal dopamine D2 receptor SPECT before and after antidepressant therapy. Psychopharmacol 126:91–94
Ebmeier K, Kronhaus D (2002) Brain imaging in mood disorders. In: D’haenen H, den Boer J, Willner P (eds) Biological psychiatry. Wiley, Chichester, pp 815–828
Hargreaves R (2002) Imaging substance P receptors (NK1) in the living human brain using positron emission tomography. J Clin Psychiatry 63[Suppl 11]: 18–24
Klimke A, Larisch R, Janz A et al (1999) Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT. Psychiatry Res Neuroimaging 90: 91–101
Laasonen-Balk T, Kuikka J, Viinamäki J et al (1999) Striatal dopamine transporter density in major depression. Psychopharmacology 144:282–285
Larisch R, Klimke A, Vosberg H et al (1997) In vivo evidence for the involvement of dopamine D2 receptors in striatum and anterior cingulate gyrus in major depression. Neuroimage 5: 251–260
Malison RT, Price LH, Berman R et al (1998) Reduced brain serotonin transporter availability in major depression as measured by [123I]-2-β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 44:1090–1098
Massou JM, Trichard C, Attar-Levy D et al (1997) Frontal 5-HT2A receptors studies in depressive patients during chronic treatment by selective serotonin reuptake inhibitors. Psychopharmacology 133:99–101
Mayberg HD, Robinson RG, Wong DF et al (1988) PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression. Am J Psychiatry 145: 937–943
Meltzer CC, Price JC, Mathis CA et al (1999) PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. Am J Psychiatry 156:1871–1878
Mertens J, Terriere D (1994) Radiosynthesis of a new radioiodinated ligand for serotonin 5-HT2 receptors, a promising tracer for λ emission tomography. J Labelled Comp Radiopharm 34: 795–806
Meyer JH, Kapur S, Houle S et al (1999) Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study. Am J Psychiatry 156:1029–1034
Meyer JH, Kapur S, Eisfeld B et al (2001) The effect of paroxetine on 5-HT2A receptors in depression: an [18F]setoperone PET imaging study. Am J Psychiatry 158:78–85
Meyer JH, Wilson AA, Ginovart N et al (2001) Occupancy of serotonin transporters by paroxetine and Citalopram during treatment of depression: a 11C-DASB PET imaging study. Am J Psychiatry 158:1843–1849
Neumeister A, Pirker W, Willeit M et al (2000) Seasonal variation of availability of serotonin transporter binding sites in healthy female subjects as measured by [123I]-2-β-carbonmeth-oxy-3β-(4-diodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 47:158–160
Paillère-Martinot ML, Bragulat V, Dollé F et al (2001) Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation. Am J Psychiatry 158:314–316
Peroutka SJ, Snyder SH (1980) Long-term antidepressant treatment decreases spiroperidol labeled serotonin receptor binding. Science 210:88–90
Pirker W, Asenbaum S, Kasper S et al (1995) β-CIT SPECT demonstrates blockade of 5-HT uptake sites by Citalopram in the human brain in vivo. J Neural Transm Gen Sect 100:247–256
Rabiner EA, Gunn RB, Wilkins MR et al (2000) Drug action at the 5-HT1A receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-11C]WAY-100635. Nucl Med Biol 27:509–513
Sargent PA, Husted K, Bench CJ et al (2000) Brain serotonin1A receptor binding measured by positron emission tomography with [11C] WAY-100635. Effects of depression and antidepressant treatment. Arch Gen Psychiatry 57:174–180
Shah PJ, Ogilvie AD, Goodwin GM, Ebmeier KP (1997) Clinical and psychometric correlates of dopamine D2 binding in depression. Psychol Med 27:1247–1256
Staley JK, Malison RT, Jnnis RB (1998) Imaging of the serotonergic system: interactions of neuro-anatomical and functional abnormalities of depression. Biol Psychiatry 44:534–549
Tauscher J, Pirker W, de Zwaan M et al (1999) In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment. Eur Neuropsychopharmacol 9:177–179
Tauscher J, Verhoeff PLG, Christensen BK et al (2001) Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C] WAY-100635 and PET. Neuropsychopharmacology 24:522–530
Willeit M, Praschak-Rieder N, Neumeister A et al (2000) [123I]β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry 47:482–489
Wust F, Carlson KE, Katzenellenbogen JA (2003) Synthesis of novel arylpyrazolocorticosteroids as potential ligands for imaging brain glucocorticoid receptors. Steroids 68:177–191
Yatham LN, Liddle PF, Dennie J et al (1999) Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment. Arch Gen Psychiatry 56:705–711
Yatham LN, Liddle PF, Shiah I-S et al (2000) Brain serotonin2 receptors in major depression. A positron emission tomography study. Arch Gen Psychiatry 57:850–858
Yatham LN, Liddle PF, Shiah IS et al (2001) Effects of rapid tryptophan depletion on brain 5-HT2 receptors: a PET study. Br J Psychiatry 178:448–453
Zanardi R, Artigas F, Moresco R et al (2001) Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. J Clin Psychopharmacol 21:53–58
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
D’haenen, H. (2004). Radioligand Studies in Depression. In: Otte, A., Audenaert, K., Peremans, K., van Heeringen, K., Dierckx, R.A. (eds) Nuclear Medicine in Psychiatry. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18773-5_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-18773-5_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62287-8
Online ISBN: 978-3-642-18773-5
eBook Packages: Springer Book Archive